For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for ...

Want to track your glucose levels without the hassle of finger pricks? A continuous glucose monitor ... Just be sure to talk to your doctor about diabetes monitor options so you can get the ...

Continuous glucose monitors, or CGMs, are devices that track blood sugar in real-time and can tell wearers how their bodies ...

We look forward to that as it’ll be a big help to anyone trying to hack diabetes care. Until then, if you need a primer on continuous glucose monitoring, we’re happy to oblige.

Discover how the first FDA-approved over-the-counter continuous glucose monitor affects the wellness industry and its potential for early diabetes diagnoses.

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it has filed for CE Mark registration for the Eversense ® 365 CGM system. Eversense 365 is the ...